Skip to main content Accessibility help

Hematopoietic Derived Cell Infiltration of the Intestinal Tumor Microenvironment in ApcMin/+ Mice

  • Celestia Davis (a1), Robert Price (a2) (a3), Grishma Acharya (a1), Troy Baudino (a3), Thomas Borg (a3), Franklin G. Berger (a1) (a2) and Maria Marjorette O. Peña (a1) (a2)...


Tumors consist of a heterogeneous population of neoplastic cells infiltrated by an equally heterogeneous collection of nonneoplastic cells that comprise the tumor microenvironment. Tumor growth, invasion, and metastasis depend on multiple interactions between these cells. To assess their potential as therapeutic targets or vehicles for tumor specific delivery of therapeutic agents, we examined the contribution of bone marrow derived cells (BMDCs) to the intestinal tumor microenvironment. Hematopoietic stem cells expressing the enhanced green fluorescent protein (eGFP) were transplanted into lethally irradiated ApcMin/+ mice, and their engraftment was analyzed by confocal microscopy. The results showed abundant infiltration of eGFP cells into the small intestine, colon, and spleen compared to heart, muscle, liver, lung, and kidney. Within the intestine, there was a pronounced gradient of engraftment along the anterior to posterior axis, with enhanced infiltration into adenomas. Immunofluorescence analysis showed that osteopontin was expressed in tumor stromal cells but not in nontumor stromal populations, suggesting that gene expression in these cells is distinct. Tumor vasculature in ApcMin/+ mice was chaotic compared to normal intestinal regions. Our data suggest that BMDCs can be harnessed for tumor-targeted therapies to enhance antitumor efficacy.


Corresponding author

Corresponding author. E-mail:


Hide All
American Cancer Society (2009). Colorectal Cancer Facts and Figures 2008–2010. Atlanta, GA: American Cancer Society.
Berger, S.H., Davis, S.T., Barbour, K.W. & Berger, F.G. (1988). The role of thymidylate synthase in the response to fluoropyrimidine-folinic acid combinations. Adv Exp Med Biol 244, 5969.
Chantrain, C.F., Feron, O., Marbaix, E. & Declerck, Y.A. (2008). Bone marrow microenvironment and tumor progression. Cancer Microenviron 1, 2335.
Chau, I. & Cunningham, D. (2006). Adjuvant therapy in colon cancer—What, when and how? Ann Oncol 17, 13471359.
Chen, L.C., Hao, C.Y., Chiu, Y.S., Wong, P., Melnick, J.S., Brotman, M., Moretto, J., Mendes, F., Smith, A.P., Bennington, J.L., Moore, D. & Lee, N.M. (2004). Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res 64, 36943700.
Coussens, L.M. & Werb, Z. (2001). Inflammatory cells and cancer: Think different! J Exp Med 193, F23F26.
Coussens, L.M. & Werb, Z. (2002). Inflammation and cancer. Nature 420, 860867.
Danenberg, P.V. (1977). Thymidylate synthetase—A target enzyme in cancer chemotherapy. Biochim Biophys Acta 473, 7392.
Denhardt, D.T. & Noda, M. (1998). Osteopontin expression and function: Role in bone remodeling. J Cell Biochem Suppl 3031, 92102.
Denhardt, D.T., Noda, M., O'Regan, A.W., Pavlin, D. & Berman, J.S. (2001). Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107, 10551061.
Erdman, S.E., Rao, V.P., Poutahidis, T., Ihrig, M.M., Ge, Z., Feng, Y., Tomczak, M., Rogers, A.B., Horwitz, B.H. & Fox, J.G. (2003). CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res 63, 60426050.
Erdman, S.E., Sohn, J.J., Rao, V.P., Nambiar, P.R., Ge, Z., Fox, J.G. & Schauer, D.B. (2005). CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 65, 39984004.
Federsppiel, B., Melhado, I.G., Duncan, A.M., Delaney, A., Schappert, K., Clark-Lewis, I. & Jirik, F.R. (1993). Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics 16, 707712.
Ferrari, N., Glod, J., Lee, J., Kobiler, D. & Fine, H.A. (2003). Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Ther 10, 647656.
Fodde, R., Kuipers, J., Rosenberg, C., Smits, R., Kielman, M., Gaspar, C., Van Es, J.H., Breukel, C., Wiegant, J., Giles, R.H. & Clevers, H. (2001). Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3, 433438.
Fuseler, J.W., Bedenbaugh, A., Yekkala, K. & Baudino, T.A. (2010). Fractal and image analysis of the microvasculature in normal intestinal submucosa and intestinal polyps in Apc(Min/+) mice. Microsc Microanal 16, 7379.
Gallagher, P.G., Bao, Y., Prorock, A., Zigrino, P., Nischt, R., Politi, V., Mauch, C., Dragulev, B. & Fox, J.W. (2005). Gene expression profiling reveals cross-talk between melanoma and fibroblasts: Implications for host-tumor interactions in metastasis. Cancer Res 65, 41344146.
Galli, S.J., Nakae, S. & Tsai, M. (2005). Mast cells in the development of adaptive immune responses. Nat Immunol 6, 135–42.
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pages, C., Tosolini, M., Camus, M., Berger, A., Wind, P., Zinzindohoue, F., Bruneval, P., Cugnenc, P.H., Trajanoski, Z., Fridman, W.H. & Pages, F. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 19601964.
Gounaris, E., Blatner, N.R., Dennis, K., Magnusson, F., Gurish, M.F., Strom, T.B., Beckhove, P., Gounari, F. & Khazaie, K. (2009). T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res 69, 54905497.
Gounaris, E., Erdman, S.E., Restaino, C., Gurish, M.F., Friend, D.S., Gounari, F., Lee, D.M., Zhang, G., Glickman, J.N., Shin, K., Rao, V.P., Poutahidis, T., Weissleder, R., McNagny, K.M. & Khazaie, K. (2007). Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci USA 104, 1997719982.
Hall, B.M., Fortney, J.E., Taylor, L., Wood, H., Wang, L., Adams, S., Davis, S. & Gibson, L.F. (2004). Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells. Cancer Lett 207, 229239.
Hanna, E., Quick, J. & Libutti, S.K. (2009). The tumour microenvironment: A novel target for cancer therapy. Oral Dis 15, 817.
Hofmeister, V., Schrama, D. & Becker, J.C. (2008). Anti-cancer therapies targeting the tumor stroma. Cancer Immunol Immunother 57, 117.
Jenq, R.R. & van den Brink, M.R. (2010). Allogeneic haematopoietic stem cell transplantation: Individualized stem cell and immune therapy of cancer. Nat Rev Cancer 10, 213221.
Jin, D.K., Shido, K., Kopp, H.G., Petit, I., Shmelkov, S.V., Young, L.M., Hooper, A.T., Amano, H., Avecilla, S.T., Heissig, B., Hattori, K., Zhang, F., Hicklin, D.J., Wu, Y., Zhu, Z., Dunn, A., Salari, H., Werb, Z., Hackett, N.R., Crystal, R.G., Lyden, D. & Rafii, S. (2006). Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12, 557567.
Kettunen, H.L., Kettunen, A.S. & Rautonen, N.E. (2003). Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer. Cancer Res 63, 51365142.
Kinzler, K.W. & Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159170.
Kitahara, O., Furukawa, Y., Tanaka, T., Kihara, C., Ono, K., Yanagawa, R., Nita, M.E., Takagi, T., Nakamura, Y. & Tsunoda, T. (2001). Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 61, 35443549.
Lin, E.Y., Nguyen, A.V., Russell, R.G. & Pollard, J.W. (2001). Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193, 727740.
Littlepage, L.E., Egeblad, M. & Werb, Z. (2005). Coevolution of cancer and stromal cellular responses. Cancer Cell 7, 499500.
Longley, D.B., Harkin, D.P. & Johnston, P.G. (2003). 5-Fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer 3, 330338.
Masuya, M., Drake, C.J., Fleming, P.A., Reilly, C.M., Zeng, H., Hill, W.D., Martin-Studdard, A., Hess, D.C. & Ogawa, M. (2003). Hematopoietic origin of glomerular mesangial cells. Blood 101, 22152218.
Moser, A.R., Dove, W.F., Roth, K.A. & Gordon, J.I. (1992). The Min (multiple intestinal neoplasia) mutation: Its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 116, 15171526.
Moser, A.R., Pitot, H.C. & Dove, W.F. (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322324.
Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S.N., Barrera, J.L., Mohar, A., Verastegui, E. & Zlotnik, A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 5056.
Nicolella, D., Maione, P. & Gridelli, C. (2003). Targeted therapies: Focus on a new strategy for gastrointestinal tumors. Crit Rev Oncol Hematol 47, 261271.
Obermueller, E., Vosseler, S., Fusenig, N.E. & Mueller, M.M. (2004). Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 64, 78017812.
Orimo, A. & Weinberg, R.A. (2006). Stromal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle 5, 15971601.
Papaspyridonos, M. & Lyden, D. (2008). Chapter 11. The role of bone marrow-derived cells in tumor angiogenesis and metastatic progression. Methods Enzymol 444, 255269.
Pietras, K., Rubin, K., Sjoblom, T., Buchdunger, E., Sjoquist, M., Heldin, C.H. & Ostman, A. (2002). Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res 62, 54765484.
Purhonen, S., Palm, J., Rossi, D., Kaskenpaa, N., Rajantie, I., Yla-Herttuala, S., Alitalo, K., Weissman, I.L. & Salven, P. (2008). Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 105, 66206625.
Rafii, S., Lyden, D., Benezra, R., Hattori, K. & Heissig, B. (2002). Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2, 826835.
Rizvi, A.Z., Swain, J.R., Davies, P.S., Bailey, A.S., Decker, A.D., Willenbring, H., Grompe, M., Fleming, W.H. & Wong, M.H. (2006). Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA 103, 63216325.
Roorda, B.D., Ter Elst, A., Kamps, W.A. & De Bont, E.S. (2009). Bone marrow-derived cells and tumor growth: Contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit Rev Oncol Hematol 69, 187198.
Salvucci, O., Basik, M., Yao, L., Bianchi, R. & Tosato, G. (2004). Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. J Leukoc Biol 76, 217226.
Schwarz, Y.X., Yang, M., Qin, D., Wu, J., Jarvis, W.D., Grant, S., Burton, G.F., Szakal, A.K. & Tew, J.G. (1999). Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents. J Immunol 163, 64426447.
Shoemaker, A.R., Gould, K.A., Luongo, C., Moser, A.R. & Dove, W.F. (1997). Studies of neoplasia in the Min mouse. Biochim Biophys Acta 1332, F25F48.
Sugiyama, Y., Farrow, B., Murillo, C., Li, J., Watanabe, H., Sugiyama, K. & Evers, B.M. (2005). Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues. Gastroenterology 128, 480486.
Vincent, J., Mignot, G., Chalmin, F., Ladoire, S., Bruchard, M., Chevriaux, A., Martin, F., Apetoh, L., Rebe, C. & Ghiringhelli, F. (2010). 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res 70, 30523061.
Wang, L., Chen, L., Benincosa, J., Fortney, J. & Gibson, L.F. (2005). VEGF-induced phosphorylation of Bcl-2 influences B lineage leukemic cell response to apoptotic stimuli. Leukemia 19, 344353.
Wang, L., Fortney, J.E. & Gibson, L.F. (2004). Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt. Leuk Res 28, 733742.
Weaver, V.M., Lelievre, S., Lakins, J.N., Chrenek, M.A., Jones, J.C., Giancotti, F., Werb, Z. & Bissell, M.J. (2002). Beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2, 205216.
Yang, L., Huang, J., Ren, X., Gorska, A.E., Chytil, A., Aakre, M., Carbone, D.P., Matrisian, L.M., Richmond, A., Lin, P.C. & Moses, H.L. (2008). Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13, 2335.


Type Description Title
Supplementary Figures

Davis et al. Supplementary Material
Davis et al. Supplementary Figures

 PDF (183 KB)
183 KB

Hematopoietic Derived Cell Infiltration of the Intestinal Tumor Microenvironment in ApcMin/+ Mice

  • Celestia Davis (a1), Robert Price (a2) (a3), Grishma Acharya (a1), Troy Baudino (a3), Thomas Borg (a3), Franklin G. Berger (a1) (a2) and Maria Marjorette O. Peña (a1) (a2)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed